Steven M. Michael, Ph.d.
Senior Vice President & European Chief Scientific Officer
BioAgilytix Labs
Romania
Biography
Since then, he led the company to become a pioneer in the area of immunogenicity, and brought the first biosimilar EPO to approval in Europe, as well as supported the first biosimilar EPO submission in the U.S. IPM Biotech was acquired by BioAgilytix in 2016, becoming BioAgilytix’s European headquarters with Dr. Kromminga as Senior Vice President & European Chief Scientific Officer. Since then, he led the company to become a pioneer in the area of immunogenicity, and brought the first biosimilar EPO to approval in Europe, as well as supported the first biosimilar EPO submission in the U.S. IPM Biotech was acquired by BioAgilytix in 2016, becoming BioAgilytix’s European headquarters with Dr. Kromminga as Senior Vice President & European Chief Scientific Officer.
Research Interest
Biopharmaceutical Science, Business Management
